Wed, 24 Jul
|Women's health technology
Commercialisation and regulatory strategies for women's health technology
Psephos will be joined by their product advisory and development partner, Sagentia Innovation for this webinar session to discuss the challenges women's health start-ups face when developing their commercialisation strategies, particularly when choosing a regulatory pathway.
![Commercialisation and regulatory strategies for women's health technology](https://static.wixstatic.com/media/f6ac4a_5a42b536369f4f1c8331a95e4478a68a~mv2.jpg/v1/fill/w_147,h_147,al_c,q_80,usm_0.66_1.00_0.01,blur_2,enc_auto/f6ac4a_5a42b536369f4f1c8331a95e4478a68a~mv2.jpg)
![Commercialisation and regulatory strategies for women's health technology](https://static.wixstatic.com/media/f6ac4a_5a42b536369f4f1c8331a95e4478a68a~mv2.jpg/v1/fill/w_147,h_147,al_c,q_80,usm_0.66_1.00_0.01,blur_2,enc_auto/f6ac4a_5a42b536369f4f1c8331a95e4478a68a~mv2.jpg)
Time & Location
24 Jul 2024, 14:00 – 15:00 BST
Women's health technology
About the event
What are the challenges women’s health start-ups face when developing their commercialisation strategies, particularly when choosing a regulatory pathway? Is it better to take a direct-to-consumer approach? Or should you pursue a regulated medical device pathway? Join Psephos and Sagenita Innovation on July 24, hosted by Science & Engineering Health Technologies Alliance (SEHTA) to find out more.
Free to attend.